Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Diabetes Care

• Publication date

  2017-08-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc17-0911PMID 28851702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.

  2017cited by this paper
• Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease

  2017cited by this paper
• Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.

  2017cited by this paper
• Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies

  2016cited by this paper
• Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice

  2016cited by this paper
• The association between endostatin and kidney disease and mortality in patients with type 2 diabetes.

  2016cited by this paper
• Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes

  2016cited by this paper
• Early detection of diabetic kidney disease: Present limitations and future perspectives.

  2016influential reference
• Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort

  2016influential reference
• The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study.

  2016cited by this paper
• Biomarkers of rapid chronic kidney disease progression in type 2 diabetes.

  2015cited by this paper
• Renal C3 Complement Component: Feed Forward to Diabetic Kidney Disease

  2015cited by this paper
• Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC–MS/MS and iTRAQ quantification

  2015cited by this paper
• Association between apolipoprotein A‐IV concentrations and chronic kidney disease in two large population‐based cohorts: results from the KORA studies

  2015cited by this paper
• Risk Prediction for Early CKD in Type 2 Diabetes.

  2015cited by this paper
• Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes

  2015influential reference
• AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease

  2015cited by this paper
• A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes

  2015cited by this paper
• GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

  2014influential reference
• Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus

  2014cited by this paper
• A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.

  2014cited by this paper
• Day-to-day variability in spot urine albumin-creatinine ratio.

  2013cited by this paper
• Cohort profile: the Fremantle Diabetes Study.

  2013cited by this paper
• Normoalbuminuric diabetic kidney disease in the U.S. population.

  2013cited by this paper
• New metrics for assessing diagnostic potential of candidate biomarkers.

  2012cited by this paper
• Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

  2012cited by this paper
• Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker

  2012cited by this paper
• IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes

  2012cited by this paper
• The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

  2011cited by this paper
• Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

  2011cited by this paper
• United States Renal Data System 2008 Annual Data Report.

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.

  2006cited by this paper
• Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.

  1999cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• J Am Soc Nephrol 13: 461–469, 2002 Apolipoprotein A-IV Serum Concentrations Are Elevated in Patients with Mild and Moderate Renal Failure

  year unknowninfluential reference

• Approaches to predict future type 2 diabetes mellitus and chronic kidney disease: A scoping review

  2025cites this paper
• Urinary apolipoprotein A4 as a biomarker for renal allograft injury in kidney transplant recipients

  2025cites this paper
• Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease

  2025cites this paper
• Serum CD5L Responds Positively to Selenium and Coenzyme Q10 Supplementation with Relation to Thyroid Hormones, Mortality, and Health-Related Quality-of-Life—A Sub-Analysis of a Double-Blind Randomised Placebo-Controlled Trial in Elderly Low in Selenium

  2025cites this paper
• PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes

  2025cites this paper
• Assessment of biomarkers associated with renal decline for prediction of incident distal sensory polyneuropathy in type 2 diabetes

  2025cites this paper
• Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease.

  2025cites this paper
• Machine Learning Models for Prediction of Diabetic Microvascular Complications

  2024cites this paper
• Comprehensive Factors for Predicting the Complications of Diabetes Mellitus: A Systematic Review

  2024influential citation
• Kidney function trajectories, associated factors, and outcomes in multiethnic Asian patients with type 2 diabetes

  2024cites this paper
• The effects of apoptosis inhibitor of macrophage in kidney diseases

  2024cites this paper
• Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II

  2024influential citation
• CD5L up-regulates the TGF-β signaling pathway and promotes renal fibrosis.

  2024cites this paper
• CD5L is upregulated upon infection with Mycobacterium tuberculosis with no effect on disease progression

  2024cites this paper
• Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome

  2024cites this paper
• Protective role for kidney TREM2high macrophages in obesity- and diabetes-induced kidney injury

  2024cites this paper
• A Composite Biomarker Signature of Type 1 Diabetes Risk Identified via Augmentation of Parallel Multi-Omics Data from a Small Cohort

  2024cites this paper
• Circulating thrombospondin-2 level for identifying individuals with rapidly declining kidney function trajectory in type 2 diabetes: a prospective study of the Hong Kong West Diabetes Registry

  2023cites this paper
• Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy

  2023cites this paper
• Gender differences-based bioinformatics analysis to identify hub genes and key pathways in type 2 diabetes

  2023cites this paper
• Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores

  2023cites this paper
• Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli

  2023cites this paper
• Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics

  2023cites this paper
• Novel biomarkers for diabetic kidney disease

  2022cites this paper
• Prediction models of diabetes complications: a scoping review

  2022cites this paper
• Screening, Early Diagnosis, Genetic Markers and Predictors of Progression

  2022cites this paper
• External validation of prognostic models for chronic kidney disease among type 2 diabetes

  2022cites this paper
• Novel Findings of Retinal and Choroidal Features Utilizing Optical Coherence Tomography Angiography Analysis in Patients With Autoimmune Posterior Uveitis

  2022cites this paper
• Associations Between the Macular Microvasculatures and Subclinical Atherosclerosis in Patients With Type 2 Diabetes: An Optical Coherence Tomography Angiography Study

  2022cites this paper
• Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease

  2022cites this paper
• Severity of depressive but not anxiety symptoms impacts glucose metabolism among patients with type 2 diabetes in primary care

  2022cites this paper
• Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis

  2022cites this paper
• Resistance Training Improved the Kidney Function of Type 2 Diabetic Patients with the Risk of Nephropathy: A Randomized Control Trial

  2022influential citation
• Diabetic kidney disease treatment: new perspectives

  2022cites this paper
• Apolipoprotein A-IV reduced metabolic inflammation in white adipose tissue by inhibiting IKK and JNK signaling in adipocytes.

  2022cites this paper
• Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study

  2022cites this paper
• Hearing and vision difficulty and sequential treatment among older adults in India

  2022cites this paper
• Personality and weight management in adults with type 2 diabetes: A systematic review

  2022influential citation
• Single-cell RNA sequencing highlights the roles of C1QB and NKG7 in the pancreatic islet immune microenvironment in type 1 diabetes mellitus.

  2022cites this paper
• Apolipoprotein A-IV Has Bi-Functional Actions in Alcoholic Hepatitis by Regulating Hepatocyte Injury and Immune Cell Infiltration

  2022cites this paper
• Obesity-instructed TREM2high macrophages identified by comparative analysis of diabetic mouse and human kidney at single cell resolution

  2021cites this paper
• Association of Diabetic Retinopathy With Stroke: A Systematic Review and Meta-Analysis

  2021influential citation
• Insulin Therapy in Type 2 Diabetes Is Associated With Barriers to Activity and Worse Health Status: A Cross-Sectional Study in Primary Care

  2021influential citation
• Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy

  2021cites this paper
• Assessment of biomarkers associated with rapid renal decline in the detection of retinopathy and its progression in type 2 diabetes: The Fremantle Diabetes Study Phase II.

  2021cites this paper
• Quantification of Human Milk Proteins and their Glycoforms using LC/MS

  2021cites this paper
• Insulin-Like Growth Factor Binding Proteins in Kidney Disease

  2021cites this paper
• Prognostic models of diabetic microvascular complications: a systematic review and meta-analysis

  2021influential citation
• Trajectories of kidney function in diabetes: a clinicopathological update

  2021cites this paper
• Rapidly progressive diabetic kidney disease: South Asian experience

  2021influential citation
• Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years

  2020cites this paper
• PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

  2020cites this paper
• Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients

  2020cites this paper
• Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion

  2020influential citation
• Biomarkers of inflammation and glomerular filtration rate in individuals with recent-onset type 1 and type 2 diabetes.

  2020cites this paper
• The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease

  2020cites this paper
• Initial Validation of a Machine Learning-Derived Prognostic Test (KidneyIntelX) Integrating Biomarkers and Electronic Health Record Data To Predict Longitudinal Kidney Outcomes.

  2020cites this paper
• A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease

  2020cites this paper
• Proteomic Analysis of Human Serum from Patients with Chronic Kidney Disease

  2020cites this paper
• Targeted and Untargeted Proteomics Approaches in Biomarker Development

  2019cites this paper
• Prediction of rapid kidney function decline using machine learning combining blood biomarkers and electronic health record data

  2019cites this paper
• Methylglyoxal down-regulates the expression of cell cycle associated genes and activates the p53 pathway in human umbilical vein endothelial cells

  2019cites this paper
• Serum Lipids and Risk of Rapid Renal Function Decline in Treated Hypertensive Adults With Normal Renal Function

  2019cites this paper
• A clinical, proteomics, and artificial intelligence‐driven model to predict acute kidney injury in patients undergoing coronary angiography

  2019cites this paper
• Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II.

  2019cites this paper
• Advances in Current Diabetes Proteomics: From the Perspectives of Label-free Quantification and Biomarker Selection.

  2019cites this paper
• Dysfunctional HDL and inflammation: a noxious liaison in adolescents with type 1 diabetes.

  2019cites this paper
• STORIA NATURALE DELLA MALATTIA RENALE NEL DIABETE E TRATTAMENTO DELL’IPERGLICEMIA NEI PAZIENTI CON DIABETE DI TIPO 2 E RIDOTTA FUNZIONE RENALE

  2019cites this paper
• Biomarkers of diabetic kidney disease

  2018cites this paper
• Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.

  2018cites this paper
• Serum ApoA4 levels predicted the progression of renal impairment in T2DM

  2018cites this paper
• Apoptosis inhibitor of macrophage and diabetic kidney disease

  2018cites this paper
• Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases.

  2018cites this paper
• Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study

  2018cites this paper
• Lower serum calcium levels are a risk factor for a decrease in eGFR in a general non-chronic kidney disease population

  2018cites this paper
• HDL in CKD-The Devil Is in the Detail.

  2018cites this paper
• Kidney as modulator and target of “good/bad” HDL

  2018cites this paper
• 10-Year Renal Function Trajectories in Community-Dwelling Older Adults: Exploring the Risk Factors for Different Patterns

  2018cites this paper
• The role of mass spectrometry in studies of glycation processes and diabetes management.

  2018cites this paper
• Overview of Older People, Ageing and Diabetes, the Disease

  2018cites this paper
• Identification of prognostic biomarkers of chronic kidney diseases in patients with type 2 diabetes

  2018cites this paper